Keywords: gsk, secures, additional, indication, coreg, fda, panel

GSK secures additional indication for Coreg from FDA panel

Article | 13 January 2003

Print This

The US Food and Drug Administration's Cardiovascular and Renal DrugsAdvisory Committee voted unanimously January 7 to back an expanded use of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in